1. Home
  2. HI vs JANX Comparison

HI vs JANX Comparison

Compare HI & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillenbrand Inc

HI

Hillenbrand Inc

HOLD

Current Price

$31.89

Market Cap

2.2B

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$15.33

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HI
JANX
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HI
JANX
Price
$31.89
$15.33
Analyst Decision
Hold
Strong Buy
Analyst Count
3
12
Target Price
$32.00
$62.00
AVG Volume (30 Days)
812.0K
2.5M
Earning Date
11-19-2025
11-06-2025
Dividend Yield
2.85%
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$2,673,800,000.00
$10,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.42
N/A
P/E Ratio
$52.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.36
$15.16
52 Week High
$35.59
$64.90

Technical Indicators

Market Signals
Indicator
HI
JANX
Relative Strength Index (RSI) 68.23 28.72
Support Level $31.80 $16.00
Resistance Level $32.07 $17.13
Average True Range (ATR) 0.10 1.55
MACD -0.09 -1.31
Stochastic Oscillator 58.89 0.99

Price Performance

Historical Comparison
HI
JANX

About HI Hillenbrand Inc

Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: